Stock AMN AMN HEALTHCARE SERVICES, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials AMN Healthcare Services, Inc.

Equities

AMN

US0017441017

Healthcare Facilities & Services

Market Closed - Nyse
Other stock markets
 04:00:01 2024-04-26 pm EDT 		5-day change 1st Jan Change
57.12 USD +1.55% Intraday chart for AMN Healthcare Services, Inc. +0.30% -23.72%
Apr. 22 Truist Lowers Price Target on AMN Healthcare Services to $70 From $88, Keeps Buy Rating MT
Feb. 28 Amn Healthcare Services Insider Bought Shares Worth $991,906, According to a Recent SEC Filing MT

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 2,911 3,210 5,783 4,456 2,830 2,164 - -
Enterprise Value (EV) 1 3,445 4,043 6,445 5,235 4,033 3,178 3,016 2,957
P/E ratio 26 x 46.1 x 18 x 10.4 x 14 x 33.5 x 22.1 x 17.5 x
Yield - - - - - - - -
Capitalization / Revenue 1.31 x 1.34 x 1.45 x 0.85 x 0.75 x 0.68 x 0.66 x 0.64 x
EV / Revenue 1.55 x 1.69 x 1.62 x 1 x 1.06 x 1 x 0.92 x 0.88 x
EV / EBITDA 12.4 x 12.6 x 10.1 x 6.18 x 6.96 x 8.81 x 7.63 x 7.69 x
EV / FCF 18.2 x 18.5 x 25.6 x 9.06 x 15 x 16.4 x 11.2 x 8.41 x
FCF Yield 5.51% 5.42% 3.91% 11% 6.66% 6.09% 8.95% 11.9%
Price to Book 3.95 x 3.92 x 5.06 x 4.13 x 3.41 x 2.51 x 2.4 x 2.27 x
Nbr of stocks (in thousands) 46,711 47,031 47,275 43,336 37,789 37,889 - -
Reference price 2 62.31 68.25 122.3 102.8 74.88 57.12 57.12 57.12
Announcement Date 2/13/20 2/18/21 2/17/22 2/16/23 2/15/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 2,222 2,394 3,984 5,243 3,789 3,182 3,293 3,364
EBITDA 1 277.4 320.7 635.4 846.7 579.1 360.8 395.3 384.6
EBIT 1 176.9 149.3 478 647.1 338.4 159.4 205 269.8
Operating Margin 7.96% 6.24% 12% 12.34% 8.93% 5.01% 6.23% 8.02%
Earnings before Tax (EBT) 1 148.5 91.52 443.9 606.7 284.3 102.1 155.7 271.4
Net income 1 114 70.66 327.4 444 210.7 72.32 111 206.3
Net margin 5.13% 2.95% 8.22% 8.47% 5.56% 2.27% 3.37% 6.13%
EPS 2 2.400 1.480 6.810 9.900 5.360 1.706 2.588 3.263
Free Cash Flow 1 189.6 219.1 251.8 577.9 268.5 193.7 269.9 351.5
FCF margin 8.53% 9.15% 6.32% 11.02% 7.09% 6.09% 8.2% 10.45%
FCF Conversion (EBITDA) 68.37% 68.33% 39.62% 68.25% 46.36% 53.68% 68.29% 91.39%
FCF Conversion (Net income) 166.37% 310.09% 76.91% 130.14% 127.43% 267.8% 243.21% 170.4%
Dividend per Share 2 - - - - - - - -
Announcement Date 2/13/20 2/18/21 2/17/22 2/16/23 2/15/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 877.8 1,363 1,553 1,427 1,139 1,126 1,126 991.3 853.5 818.3 816.5 780.3 774.9 794.9 815.2
EBITDA 1 138.4 222.6 257.6 232.7 181.8 174.6 179.6 161.8 133.7 104 93.6 87.7 88.17 91.21 95.25
EBIT 1 105.8 168.6 207.9 183.5 136.4 119.3 125.7 91.66 86.93 34.17 40.41 37.96 39.06 41.2 43.8
Operating Margin 12.06% 12.37% 13.39% 12.87% 11.98% 10.6% 11.16% 9.25% 10.19% 4.18% 4.95% 4.86% 5.04% 5.18% 5.37%
Earnings before Tax (EBT) 1 100.6 158.8 198.3 173.5 127.4 107.5 115.4 79.49 75.38 14 21.82 22.14 24.96 29.19 29.16
Net income 1 74.02 116.2 146 123.8 92.44 81.8 84.11 60.91 53.17 12.49 15.03 16.58 18.66 21.61 20.58
Net margin 8.43% 8.53% 9.4% 8.68% 8.12% 7.27% 7.47% 6.14% 6.23% 1.53% 1.84% 2.12% 2.41% 2.72% 2.52%
EPS 2 1.540 2.420 3.090 2.770 2.100 1.880 2.020 1.550 1.390 0.3300 0.3931 0.3836 0.4148 0.4860 0.4101
Dividend per Share 2 - - - - - - - - - - - - - - -
Announcement Date 11/4/21 2/17/22 5/5/22 8/4/22 11/3/22 2/16/23 5/4/23 8/3/23 11/2/23 2/15/24 - - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt 1 534 833 661 779 1,203 1,014 852 793
Net Cash position 1 - - - - - - - -
Leverage (Debt/EBITDA) 1.926 x 2.599 x 1.041 x 0.92 x 2.077 x 2.81 x 2.156 x 2.062 x
Free Cash Flow 1 190 219 252 578 268 194 270 351
ROE (net income / shareholders' equity) 16.6% 9.08% 33% 40.3% 22.5% 14.6% 18% 18.4%
ROA (Net income/ Total Assets) 6.66% 3.3% 11.9% 14.8% 7.25% 2.6% 5.9% 6.6%
Assets 1 1,712 2,143 2,743 3,010 2,906 2,782 1,881 3,125
Book Value Per Share 2 15.80 17.40 24.20 24.90 22.00 22.70 23.80 25.10
Cash Flow per Share 2 4.720 5.390 6.360 14.60 9.460 6.000 7.180 9.820
Capex 1 35.2 37.7 53.6 75.8 104 68.2 73.7 69.5
Capex / Sales 1.58% 1.58% 1.34% 1.45% 2.74% 2.14% 2.24% 2.07%
Announcement Date 2/13/20 2/18/21 2/17/22 2/16/23 2/15/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for AMN Healthcare Services, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
A-
More Ratings

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
10
Last Close Price
57.12 USD
Average target price
75.12 USD
Spread / Average Target
+31.52%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Healthcare Facilities & Services

1st Jan change Capi.
AMN HEALTHCARE SERVICES, INC. Stock AMN Healthcare Services, Inc.
-23.72% 2.16B
CVS HEALTH CORPORATION Stock CVS Health Corporation
-14.92% 84.68B
HCA HEALTHCARE, INC. Stock HCA Healthcare, Inc.
+13.30% 81.12B
DR. SULAIMAN AL HABIB MEDICAL SERVICES GROUP COMPANY Stock Dr. Sulaiman Al Habib Medical Services Group Company
+10.92% 29.4B
LABORATORY CORPORATION OF AMERICA HOLDINGS Stock Laboratory Corporation of America Holdings
-12.71% 16.73B
FRESENIUS SE & CO. KGAA Stock Fresenius SE & Co. KGaA
-3.06% 16.36B
QUEST DIAGNOSTICS INCORPORATED Stock Quest Diagnostics Incorporated
-2.63% 14.92B
EUROFINS SCIENTIFIC SE Stock Eurofins Scientific SE
-3.97% 11.66B
FRESENIUS MEDICAL CARE AG Stock Fresenius Medical Care AG
-1.42% 11.72B
PURE HEALTH HOLDING Stock Pure Health Holding
-31.75% 11.77B
Other Healthcare Facilities & Services
  1. Stock Market
  2. Equities
  3. AMN Stock
  4. Financials AMN Healthcare Services, Inc.